The tumor volume on day 30 was significantly, ~4-fold lower in the DJ4-treated OCI-AML3–YFP–Luc mice versus the control group (Figure 6D), and the tumor weight was significantly reduced (~3-fold) (Figure 6E). This evidence concerns the gene RUNX2 and neoplasm.